1. 334PDTumor Treating Fields (TTFields) – A novel cancer treatment modality: Translating preclinical evidence and engineering into a survival benefit with delayed decline in quality of life. (18th September 2017) Authors: Stupp, R.; Taphoorn, M.; Dirven, L.; Taillibert, S.; Honnorat, J.; Chen, T.; Sroubek, J.; Paek, S.H.; Bruna Escuder, J.; Easaw, J.; David, C.; Kim, C.Y.; Desai, R.; Kew, Y.; Olivi, A.; Hottinger, A.; Kirson, E.D.; Lavy-Shahaf, G.; Hegi, M.E.; Ram, Z. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. (May 2018) Authors: Gao, Y.; Weenink, B.; van den Bent, M.J.; Erdem-Eraslan, L.; Kros, J.M.; Sillevis Smitt, PAE; Hoang-Xuan, K.; Brandes, A.A.; Vos, M.; Dhermain, F.; Enting, R.; Ryan, G.F.; Chinot, O.; Ben Hassel, M.; van Linde, M.E.; Mason, W.P.; Gijtenbeek, J.M.M.; Balana, C.; von Deimling, A.; Gorlia, Th Journal: European journal of cancer Issue: Volume 94(2018) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lessons from translational research in EORTC glioma trials. (15th February 2016) Authors: Hegi, M.E. Journal: Radiotherapy and oncology Issue: Volume 118(2016)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗